Bioject to Report Fiscal 2003 Second-Quarter Results On October 24, 2002.

Business Editors

BEDMINSTER, N.J.--(BUSINESS WIRE)--Oct. 16, 2002

Bioject Medical Technologies Inc., (Nasdaq: BJCT), a leading developer of needle-free drug delivery systems, announced today that the Company will report its fiscal 2003 second-quarter financial results on Thursday, October 24, 2002, after the close of the financial markets. Management will conduct a conference call on Friday, October 25, 2002, at 10:00 a.m. Eastern Daylight Time to review the results for the quarter. Jim O'Shea, Chairman, President, and CEO, and John Gandolfo, Chief Financial Officer, will be hosting the call.

Live audio of the conference call will be simultaneously broadcast over the Internet and will be available to investors, members of the news media and the general public. To participate in the call via telephone, please dial 1-800-432-7890, or to access the call live over the Internet, visit Bioject's website at www.bioject.com and click on the Investor Relations section, then on the event icon. A conference call replay will also be available until October 31, 2002. To listen to the replay, please dial 1-800-428-6051, replay pass code 265058.

Bioject Medical Technologies Inc., based in Bedminster, New Jersey, with manufacturing facilities in Portland, Oregon, is an innovative developer and manufacturer of needle-free drug delivery systems. Needle-free injection works by forcing medication at high speed through a tiny orifice held against the skin. This creates a fine stream of high-pressure fluid penetrating the skin and depositing medication in the tissue beneath. The Company is focused on developing mutually beneficial agreements with leading pharmaceutical and biotechnology companies. Bioject's strategic partners include Serono, Alkermes and Merial.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Readers of this press release are referred to the Company's filings with the Securities and Exchange Commission, including the Company's reports on Forms 10-K and Forms 10-Q for further discussions of factors that could affect future results. Forward-looking statements are based on the estimates and opinions of management on the date the statements are made. The Company assumes no obligation to update forward-looking statements if conditions or management's estimates or opinions should change.

For more information about Bioject, visit: www.bioject.com.